Drug intelligence / Profile preview

cholera toxin B subunit

Development stage
Phase 1
Lead developer
Valneva
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Oral
01

Overview

The **cholera toxin B subunit** is the non-toxic, receptor-binding component of cholera toxin from *Vibrio cholerae*. Structurally, it forms a homopentamer, each subunit ~11 kDa, which binds tightly to the ganglioside GM1 on cell surfaces, facilitating toxin uptake. Unlike the toxic A subunit, the B subunit alone does not induce toxicity or adenylate cyclase activation. It is used in the licensed cholera vaccine Dukoral and is being explored as an immunomodulatory agent and mucosal vaccine adjuvant. CTB stimulates strong mucosal and systemic immune responses, induces immunotolerance, and has demonstrated anti-inflammatory and wound healing properties in preclinical models. CTB is also widely used as a neuronal tracer due to its efficient retrograde transport and as a probe for studying lipid rafts and membrane trafficking in cell biology[1][3][4][5].

Brand names
Dukoral
Other names
CTBCTxBcholera toxin Brecombinant cholera toxin B subunitrCTB
02

Targets

GM1 (GM1 ganglioside)

Beyond the preview

Go deeper on cholera toxin B subunit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cholera toxin B subunit.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call